Presence of methicillin-resistant Staphylococcus aureus (MRSA) strains carrying plasmid-borne multidrug efflux pump-encoding gene, qacA/B, is a serious issue for infection control in hospitals, because they can survive hand hygiene. The qacA/B genes are divided into five subtypes: qacA, qacBI, qacBII, qacBIII, and qacBIV. The aim of this study was to investigate the prevalence and risk factors of hospitalized patients infected by respective qacA/B-positive MRSA strains between 2010 and 2016 in Tokyo, Japan. Of the 600 total MRSA strains observed, the qacA/B-positive strains constituted 19.8% (199 isolates), of which 56.8% (113 isolates), 28.6% (57 isolates), and 14.6% (29 isolates) were classified as qacA, qacBIII, and qacBII-positive strains, respectively. The prevalence of qacA-positive MRSA strains significantly decreased from July 2010 to June 2011 (34.0%) to July 2015 to May 2016 (5.3%) (p < 0.05). When staphylococcal cassette chromosome (SCC)mec types of the respective qacA/B-positive strains were determined, 81.4% of the qacA-positive strains were classified into SCCmec type II, which has recently been decreasing in hospital-acquired MRSA in Japan. Risk factor analysis showed that there were no specific clinical departments associated with the presence of qacA-positive strains. Our findings suggest that change in the MRSA clonal lineages impact to decrease the prevalence of qacA-positive strains in Japanese hospitals.
Get full access to this article
View all access options for this article.
References
1.
LakhundiS., and ZhangK.. 2018. Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin. Microbiol. Rev. 31:e00020-18.
2.
MarimuthuK., PittetD., and HarbarthS.. 2014. The effect of improved hand hygiene on nosocomial MRSA control. Antimicrob. Resist. Infect. Control. 3:34.
3.
ChalfineA., KitzisM.D., BezieY., BenaliA., PerniceniL., NguyenJ.C., DumayM.F., GonotJ., RejasseG., GoldsteinF., CarletJ., and MissetB.. 2012. Ten-year decrease of acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteremia at a single institution: the result of a multifaceted program combining cross-transmission prevention and antimicrobial stewardship. Antimicrob. Resist. Infect. Control. 1:18.
4.
McNeilJ.C., HultenK.G., MasonE.O., and KaplanS.L.. 2017. Impact of health care exposure on genotypic antiseptic tolerance in Staphylococcus aureus infections in a pediatric population. Antimicrob. Agents Chemother. 61:e00223–00217.
5.
NoguchiN., HaseM., KittaM., SasatsuM., DeguchiK., and KonoM.. 1999. Antiseptic susceptibility and distribution of antiseptic-resistance genes in methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 172:247–253.
6.
NoguchiN., SuwaJ., NaruiK., SasatsuM., ItoT., HiramatsuK., and SongJ.H.. 2005. Susceptibilities to antiseptic agents and distribution of antiseptic-resistance genes qacA/B and smr of methicillin-resistant Staphylococcus aureus isolated in Asia during 1998 and 1999. J. Med. Microbiol. 54:557–565.
7.
NoguchiN., NakaminamiH., NishijimaS., KurokawaI., SoH., and SasatsuM.. 2006. Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome. J. Clin. Microbiol. 44:2119–2125.
8.
MayerS., BoosM., BeyerA., FluitA.C., and SchmitzF.J.. 2001. Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 47:896–897.
9.
AlamM.M., KobayashiN., UeharaN., and WatanabeN.. 2003. Analysis on distribution and genomic diversity of high-level antiseptic resistance genes qacA and qacB in human clinical isolates of Staphylococcus aureus. Microb. Drug Resist. 9:109–121.
10.
LittlejohnT.G., PaulsenI.T., GillespieM.T., TennentJ.M., MidgleyM., JonesI.G., PurewalA.S., and SkurrayR.A.. 1992. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 74:259–265.
11.
McDonnellG., and RussellA.D.. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev. 12:147–179.
PaulsenI.T., BrownM.H., LittlejohnT.G., MitchellB.A., and SkurrayR.A.. 1996. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc. Natl. Acad. Sci. U.S.A. 93:3630–3635.
14.
MitchellB.A., BrownM.H., and SkurrayR.A.. 1998. QacA multidrug efflux pump from Staphylococcus aureus: comparative analysis of resistance to diamidines, biguanidines, and guanylhydrazones. Antimicrob. Agents Chemother. 42:475–477.
15.
NakaminamiH., NoguchiN., and SasatsuM.. 2010. Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus. Antimicrob. Agents Chemother. 54:4107–4111.
16.
ChoO.H., ParkK.H., SongJ.Y., HongJ.M., KimT., HongS.I., KimS., and BaeI.G.. 2018. Prevalence and microbiological characteristics of qacA/B-positive methicillin-resistant Staphylococcus aureus isolates in a surgical intensive care unit. Microb. Drug Resist. 24:283–289.
17.
HornerC., UtsiL., CooleL., and DentonM.. 2017. Epidemiology and microbiological characterization of clinical isolates of Staphylococcus aureus in a single healthcare region of the UK, 2015. Epidemiol. Infect. 145:386–396.
18.
ValiL., DashtiA.A., MathewF., and UdoE.E.. 2017. Characterization of heterogeneous MRSA and MSSA with reduced susceptibility to chlorhexidine in Kuwaiti hospitals. Front. Microbiol. 8:1359.
19.
HaydenM.K., LolansK., HaffenrefferK., AveryT.R., KleinmanK., LiH., KaganovR.E., LankiewiczJ., MoodyJ., SeptimusE., WeinsteinR.A., HickokJ., JerniganJ., PerlinJ.B., PlattR., and HuangS.S.. 2016. Chlorhexidine and mupirocin susceptibility of methicillin-resistant Staphylococcus aureus isolates in the REDUCE-MRSA trial. J. Clin. Microbiol. 54:2735–2742.
20.
HaradaD., NakaminamiH., MiyajimaE., SugiyamaT., SasaiN., KitamuraY., TamuraT., KawakuboT., and NoguchiN.. 2018. Change in genotype of methicillin-resistant Staphylococcus aureus (MRSA) affects the antibiogram of hospital-acquired MRSA. J. Infect. Chemother. 24:563–569.
21.
DavidM.Z., CadillaA., Boyle-VavraS., and DaumR.S.. 2014. Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004–5 to 2008. PLoS One, 9:e92760.
22.
KondoY., ItoT., MaX.X., WatanabeS., KreiswirthB.N., EtienneJ., and HiramatsuK.. 2007. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob. Agents Chemother. 51:264–274.
23.
HirotakiS., SasakiT., Kuwahara-AraiK., and HiramatsuK.. 2011. Rapid and accurate identification of human-associated staphylococci by use of multiplex PCR. J. Clin. Microbiol. 49:3627–3631.
24.
GutellR.R., LarsenN., and WoeseC.R.. 1994. Lessons from an evolving rRNA: 16S and 23S rRNA structures from a comparative perspective. Microbiol. Rev. 58:10–26.
25.
NakaminamiH., NoguchiN., IkedaM., HasuiM., SatoM., YamamotoS., YoshidaT., AsanoT., SenoueM., and SasatsuM.. 2008. Molecular epidemiology and antimicrobial susceptibilities of 273 exfoliative toxin-encoding-gene-positive Staphylococcus aureus isolates from patients with impetigo in Japan. J. Med. Microbiol. 57:1251–1258.
26.
NakaminamiH., NoguchiN., NishijimaS., KurokawaI., SoH., and SasatsuM.. 2007. Transduction of the plasmid encoding antiseptic resistance gene qacB in Staphylococcus aureus. Biol. Pharm. Bull. 30:1412–1415.
27.
TakadamaS., NakaminamiH., SatoA., ShoshiM., FujiiT., and NoguchiN.. 2018. Dissemination of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus USA300 clone in multiple hospitals in Tokyo, Japan. Clin. Microbiol. Infect., 24:1211.e1211–e1217.
28.
NakaminamiH., TakadamaS., ItoA., HasegawaM., JonoC., NoguchiM., ShoshiM., WajimaT., FujiiT., MaruyamaH., SakamotoH., ItoY., OkamotoS., MasakiY., TsuchiyaK., NishinaritaS., and NoguchiN.. 2018. Characterization of SCCmec type IV methicillin-resistant Staphylococcus aureus clones increased in Japanese hospitals. J. Med. Microbiol. 67:769–774.
29.
NakaminamiH., NoguchiN., ItoA., IkedaM., UtsumiK., MaruyamaH., SakamotoH., SenooM., TakasatoY., and NishinaritaS.. 2014. Characterization of methicillin-resistant Staphylococcus aureus isolated from tertiary care hospitals in Tokyo, Japan. J. Infect. Chemother. 20:512–515.
30.
TakadamaS., NakaminamiH., AokiS., AkashiM., WajimaT., IkedaM., MochidaA., ShimoeF., KimuraK., MatsuzakiY., SawamuraD., InabaY., OishiT., NemotoO., BabaN., and NoguchiN.. 2017. Prevalence of skin infections caused by Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Japan, particularly in Ishigaki, Okinawa. J. Infect. Chemother. 23:800–803.
31.
TsutsuiA., YaharaK., and ShibayamaK.. 2018. Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016. J. Infect. Chemother. 24:414–421.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
